Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05246475 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Measurement of Head and Neck Tumor Hypoxia With PET-MRI

Study acronym: EF5NECK
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 18, 2022 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This study is designed to evaluate the performance of advanced magnetic resonance (MR) imaging in the assessment of tumor hypoxia using \[18F\]EF5 positron emission tomography (PET) as a reference in head and neck cancer patients. Low oxygen level or hypoxia contributes to radiotherapy resistance. Therefore, a clinically applicable method to detect tumor hypoxia is of great importance.
Trial Details
NCT Number NCT05246475
Lead Sponsor Turku University Hospital
Conditions
(from sponsor)		 Head and Neck Cancer
Related terms Head and Neck Neoplasms
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov